Business, Policy & Funding
Breaking news on diagnostics business, policy, and funding.
International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time
Researchers laid out a set of ethical, organizational, and technical guidelines for the development, commercial use, and clinical implementation of microbiome tests.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
In Brief This Week: Myriad Genetics, Thermo Fisher Scientific, DeepUll, Roche, Immunovia, More
News items for the weeks of Nov. 25 and Dec. 2, 2024.
GeneDx Launches Program to Boost Access to Exome Testing for Pediatric Epilepsy Patients
In partnership with Biogen, Praxis Precision Medicines, and Stoke Therapeutics, the program will also contribute to GeneDx's rare disease database.
LGC Acquires German Quality Controls Maker DiaMex
DiaMex is a manufacturer of third-party serology and molecular quality controls for clinical laboratories and blood banks.
Nov 27, 2024
Prenetics Q3 Revenues up 59 Percent
Nov 25, 2024
Agilent Reorganizes Business Units
Nov 25, 2024